
Supercharging AI-drug discovery with strategic multiomic biobanks
Niven R. Narain, PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market. Artificial Intelligence (AI) has become a popular buzzword in the drug discovery and development lexicon but not all approaches to AI-driven… Read More














